Evidence map›Paper›PMID 26856437›Full record

Trial reportScientific reports2016

Integrated analysis of the involvement of nitric oxide synthesis in mitochondrial proliferation, mitochondrial deficiency and apoptosis in skeletal muscle fibres.

Gabriela Silva Rodrigues, Rosely Oliveira Godinho, Beatriz Hitomi Kiyomoto, Juliana Gamba, Acary Souza Bulle Oliveira, Beny Schmidt, Célia Harumi Tengan

Erratum issuedOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Protein Nitration in Patients with Mitochondrial Diseases.Antioxidants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. NO control of mitochondrial function in normal and transformed cells.Biochimica et biophysica acta. Bioenergetics · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gabriela Silva RodriguesDepartment of Neurology &Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo;São Paulo, Brazil.
Rosely Oliveira GodinhoDivision of Cellular Pharmacology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Beatriz Hitomi KiyomotoDepartment of Neurology &Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo;São Paulo, Brazil.
Juliana GambaDepartment of Neurology &Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo;São Paulo, Brazil.
Acary Souza Bulle OliveiraDepartment of Neurology &Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo;São Paulo, Brazil.
Beny SchmidtDepartment of Pathology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Célia Harumi TenganDepartment of Neurology &Neurosurgery, Escola Paulista de Medicina, Universidade Federal de São Paulo;São Paulo, Brazil.
Universidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) is an important signaling messenger involved in different mitochondrial processes but only few studies explored the participation of NO in mitochondrial abnormalities found in patients with genetic mitochondrial deficiencies. In this study we verified whether NO synthase (NOS) activity was altered in different types of mitochondrial abnormalities and whether changes in mitochondrial function and NOS activity could be associated with the induction of apoptosis. We performed a quantitative and integrated analysis of NOS activity in individual muscle fibres of patients with mitochondrial diseases, considering mitochondrial function (cytochrome-c-oxidase activity), mitochondrial content, mitochondrial DNA mutation and presence of apoptotic nuclei. Our results indicated that sarcolemmal NOS activity was increased in muscle fibres with mitochondrial proliferation, supporting the relevance of neuronal NOS in the mitochondrial biogenesis process. Sarcoplasmic NOS activity was reduced in cytochrome-c-oxidase deficient fibres, probably as a consequence of the involvement of NO in the regulation of the respiratory chain. Alterations in NOS activity or mitochondrial abnormalities were not predisposing factors to apoptotic nuclei. Taken together, our results show that NO can be considered a potential molecular target for strategies to increase mitochondrial content and indicate that this approach may not be associated with increased apoptotic events.

Indexed as

ApoptosisMitochondrial DynamicsAdolescentAdultAgedChildChild, PreschoolFemaleHumansMaleMiddle AgedMitochondrial DiseasesMitochondrial ProteinsMitochondria, MuscleMuscle Fibers, SkeletalMuscle ProteinsMitochondrial ProteinsMuscle ProteinsNitric OxideNitric Oxide Synthase

Identifiers

PMID26856437
PMCPMC4746761
OpenAlexW2416095794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.